Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: whenever (69), consistently (83), always (690)

Bevacizumab-Irinotecan Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-IRINOTECAN This protocol may require funding Regimen Colorectal Cancer – Bevacizumab-Irino
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-IrinotecanVer11.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This r
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

Temozolomide RT (7 day)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE RT (7 day) Regimen • CNS – Temozolomide RT (7 day) Indication • Firs
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-RT-7-day.pdf

Azathioprine for interstitial lung disease (ILD) - patient information

Description: This factsheet contains useful information about the medicine azathioprine.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Azathioprine-for-interstitial-lung-disease-ILD-patient-information.pdf

ACCORD-2 master protocol

Description: CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Pha
Url: /Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf

PIS COVID-19 immsup adults V2.1

Description: Participant Information Study Title: Coronavirus infection in immunosuppressed children and adults. Chief Investigator: H. de Graaf Pr
Url: /Media/Southampton-Clinical-Research/COVID-19/ImmunoCOVID/PIS-COVID-19-immsup-adults-V2.1.pdf

ImmunoCOVID19 info for parents or carers and children aged 16-17

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary im
Url: /Media/Southampton-Clinical-Research/Downloads/Immunocovid/ImmunoCOVID19-info-for-parents-or-carers-and-children-aged-16-17.pdf

PIS COVID-19 immsup child - over 16 yrs and parents V1.6

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary im
Url: /Media/Southampton-Clinical-Research/COVID-19/PIS-COVID-19-immsup-child-over-16-yrs-and-parents-V1.6.pdf

Press release: Southampton's Princess Anne Hospital to go purple for World Prematurity Day

Description: Southampton's Princess Anne Hospital will go purple to mark World Prematurity Day on Sunday, 17 November – before staff, parents and babies
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/November/Press-release-Southamptons-Princess-Anne-Hospital-to-go-purple-for-World-Prematurity-Day.aspx

491 to 500 of 762

Previous … 48 49 50 51 52 … Next